NYSE:DOCS - New York Stock Exchange, Inc. - US26622P1075 - Common Stock - Currency: USD
Markets ended the week strong, powered by trade optimism and tech momentum. But weak consumer sentiment and inflation concerns linger beneath the surface.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
NEW YORK (Reuters) -U.S. stocks fell on Friday, notching a weekly loss, after President Donald Trump recommended 50% tariffs on European goods, reopening a new front in global trade tensions and unleashing a fresh wave of market uncertainty. All three main Wall Street indexes pared early losses but each still ended lower and shed more than 2% for the week. Technology, communication services and consumer discretionary stocks were the biggest losers of the S&P 500's 11 subsectors.
On May 22, Air Products and Chemicals, Inc. (NYSE:APD) declared a quarterly dividend of $1.79 per share, which was in line with its previous dividend. Air Products and Chemicals, Inc. (NYSE:APD) is an American multinational company that is known for its industrial gases, performance materials, and associated equipment and services. The company has maintained a […]
We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at where Doximity, Inc. (NYSE:DOCS) stands against other stocks that Jim Cramer discussed recently. Noting that the stock tanked after earnings on weak guidance, a caller asked for Cramer’s opinion of Doximity, […]
Rivian Automotive is better than this EV rival that missed analyst estimates of $250 million, according to Benzinga Pro.
Discover the benefits and considerations of annuities in retirement planning.
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS)...
Digital medical platform leader Doximity reported better-than-expected results on the top and bottom lines. Free cash flow grew by more than 50% year over year, and margins are stellar. At first glance, Doximity's earnings report looked rather strong.
A significant trading signal occurred for Doximity stock at a price of $49.24, after which DOCS rose up to 7.8%.
DOXIMITY INC (NYSE:DOCS) is an affordable growth stock with strong profitability, zero debt, and solid earnings growth, trading at a reasonable valuation relative to peers.
The company reported a strong Q4 with 17% revenue growth but saw shares drop 20% after hours following conservative FY26 revenue and Q1 guidance that missed analyst estimates.
Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.
Doximity (DOCS) delivered earnings and revenue surprises of 40.74% and 3.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PACS
It powered well past analyst estimates for both revenue and net income. The sun was shining brightly on solar industry technology specialist Nextracker's (NASDAQ: NXT) stock on Thursday. After the company crushed analyst estimates in its latest quarterly-earnings report, satisfied investors pushed its share price up by nearly 12%, obliterating the S&P 500 index's 0.4% increase.
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
Doximity's Q4 performance likely witnessed strong product-driven gains from new modules and integrated programs, though early revenue pull-forward might have tempered sequential growth.
DOXIMITY INC-CLASS A (NYSE:DOCS) has a strong technical rating of 8 out of 10, indicating a potential breakout.